Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
about
Is there a role for carbohydrate restriction in the treatment and prevention of cancer?Unraveling insulin-like growth factor binding protein-3 actions in human diseaseThe Insulin/IGF System in Colorectal Cancer Development and Resistance to TherapyUnderstanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentDiabetes and cancer: a consensus report.Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis.Epidemiological and molecular mechanisms aspects linking obesity and cancer.Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study.Obesity is an independent prognostic variable in colon cancer survivors.Obesity adversely affects survival in pancreatic cancer patients.Energetics in colorectal and prostate cancer.Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies.Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancerDiet and lifestyle in survivors of colorectal cancer.Diabetes mellitus and colorectal cancer prognosis: a meta-analysisSerum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.Post diagnosis diet quality and colorectal cancer survival in womenA randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer.Colorectal cancer survivorship: movement matters.Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine.A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin.Visceral adiposity, insulin resistance and cancer risk.Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumorsThe Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis.Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29.The role of obesity in cancer survival and recurrence.Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway.Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803
P2860
Q21245058-69E914B4-94B6-4A10-94EE-74E1888D707CQ24650060-1753271C-9131-4253-BE07-4BEE316F290FQ26777125-E0626D12-656D-4FDB-B3FF-ABEAF4C99C4FQ26798408-DC733435-02DE-4A3A-B142-F45120D53D58Q27686977-0F371F5E-8331-4DCC-9341-8E7D488D18C7Q28081844-B1D794C7-85AA-4FB9-A827-D98928954FA8Q30249342-9B6406B2-3DE7-4C99-A06A-B14BC8C203AAQ30377470-0F36DF25-C140-4100-BE0B-D8E89683B27BQ33768908-63F28BAD-EC65-422A-A44D-221559FCDFF7Q34008787-BE746006-AEA5-41B3-A11B-AD48F77BC31FQ34069086-842479A5-8567-4E24-B45C-F7A4D249385DQ34153922-EC3E9D54-EA76-4DAB-BAF6-C8832860DE92Q34168070-D61A84A2-FEF4-4A15-9CD4-7F52B037EF97Q34238737-25594DEE-C44A-4556-8F9E-D2DCD8B56AF0Q34315768-13D22653-2329-4A62-B4AD-F2E7E6D0B611Q34334262-121435EB-2E6F-44FB-87BD-F96038C36E78Q34418980-C9981409-ECE3-453D-8F55-63523A5B74CCQ34468759-0ECCAB06-4450-4A63-87F1-C2D3378B260FQ34577559-5E92CCE4-8FA1-49E2-81DF-14DA3913F30AQ34577576-319657E2-7EEC-4752-B303-90FD4A75D39EQ34650201-FB2711E1-C8C6-4E63-8A24-19A4E2304CA3Q34656583-A3B95B66-906F-4A38-9A28-A7E5E60571CAQ34687505-C99F7BD6-76FF-4F23-96EE-FAD0ECD91705Q34704526-29A09F8B-7535-4BD9-9338-92CBD1AC6743Q35000503-CEC4D32F-E212-462F-A4B2-D70BDBC676B3Q35032998-260F7E23-F506-4FA4-9233-4069AC5E3E71Q35097723-04CDAA32-D01F-402A-9CBC-1C5742439E55Q35119536-1F7EEEB0-4184-422A-890B-3DE9A10838DEQ35133640-36840A5E-0F15-4276-96A8-9C84723DEC87Q35226507-3F43DB3B-39DF-42FA-8588-54D481712461Q35609517-AB7D4B6F-116A-4AD0-AAC0-DF76A9862CDCQ35748185-A27C6097-79DA-4CFB-BC60-9EEA381E70F1Q36010516-1671ABEB-9626-431B-ADEE-100632A7755EQ36078978-3F8D1804-8500-4C9B-8B7C-50AB5692ACC8Q36097117-4FEAA10F-0C69-43AB-AEAD-6A1F2EAD81CAQ36152955-5DBFC764-CA65-480A-873F-9095850F297FQ36260667-BEDB5885-D096-4836-9BB8-86C4647BE2B5Q36265430-5215BEE6-2863-41A8-987A-30C3B6107F56Q36334079-D2C37B4E-AC38-4D8C-A974-8FAE40725CC1Q36411742-27935DDF-2F88-4F48-A754-28F16614A822
P2860
Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin, the insulin-like grow ...... nmetastatic colorectal cancer.
@en
Insulin, the insulin-like grow ...... nmetastatic colorectal cancer.
@nl
type
label
Insulin, the insulin-like grow ...... nmetastatic colorectal cancer.
@en
Insulin, the insulin-like grow ...... nmetastatic colorectal cancer.
@nl
prefLabel
Insulin, the insulin-like grow ...... nmetastatic colorectal cancer.
@en
Insulin, the insulin-like grow ...... nmetastatic colorectal cancer.
@nl
P2093
P2860
P50
P921
P356
P1476
Insulin, the insulin-like grow ...... nmetastatic colorectal cancer.
@en
P2093
Andrew T Chan
Brian M Wolpin
Jennifer A Chan
Michael N Pollak
P2860
P304
P356
10.1200/JCO.2008.17.9945
P407
P577
2008-12-08T00:00:00Z